XAIR - Beyond Air® To Participate in the Roth MKM 2023 Healthcare Opportunities Conference | Benzinga
GARDEN CITY, N.Y., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ:XAIR) ("Beyond Air" or the "Company") a commercial stage medical device and biopharmaceutical company focused on harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders and solid tumors (through its affiliate Beyond Cancer, Ltd.), today announced that the Company will present a corporate overview and participate in one-on-one meetings at the Roth MKM 2023 Healthcare Opportunities Conference being held on Thursday, October 12, 2023 in New York City, NY.
Roth MKM 2023 Healthcare Opportunities Conference: October 12, 2023
| Title: |
| Beyond Air (NASDAQ:XAIR) Company Presentation |
| Date & Time: |
| Thursday, October 12th |
| Participants: |
| Duncan Fatkin, Chief Commercial Officer, Beyond Air |
| Douglas Larson, Chief Financial Officer, Beyond Air |